Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
7.73
-0.20 (-2.52%)
At close: Apr 28, 2026, 4:00 PM EDT
7.67
-0.06 (-0.78%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Adicet Bio Employees
Adicet Bio had 102 employees as of December 31, 2025. The number of employees decreased by 50 or -32.89% compared to the previous year.
Employees
102
Change (1Y)
-50
Growth (1Y)
-32.89%
Revenue / Employee
n/a
Profits / Employee
-$1,145,127
Market Cap
83.09M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Gossamer Bio | 162 |
| Sangamo Therapeutics | 142 |
| PolyPid | 75 |
| eXoZymes | 32 |
| NeurAxis | 24 |
| Q32 Bio | 24 |
| Gain Therapeutics | 21 |
ACET News
- 6 weeks ago - Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress - Business Wire
- 3 months ago - Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - Business Wire
- 3 months ago - Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones - Business Wire
- 4 months ago - Adicet Bio Announces Reverse Stock Split - Business Wire
- 5 months ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 months ago - Adicet Bio Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference - Transcripts
- 6 months ago - Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire
- 6 months ago - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire